NICE publish guideline on hypertension in pregnancy: diagnosis and management
- assessing proteinuria (the presence of abnormal quantities of protein in the urine)
- managing chronic hypertension in pregnancy and gestational hypertension
- managing pre-eclampsia, including severe pre-eclampsia in critical care settings (eclampsia is where convulsions occur in a pregnant woman suffering from high blood pressure)
- treatment during the postnatal period (including breastfeeding)
- advice and follow-up in community care
- reducing the risk of hypertension in pregnancy
- fetal monitoring and care of women during labour and birth
- Women who develop hypertension during pregnancy, who have hypertension and wish to conceive, and who have had a pregnancy complicated by hypertension, and their relatives and carers
- Healthcare professionals
- pregnant women who develop high blood pressure are offered the right tests and treatments to keep their blood pressure within a safe range for them and their baby
- women who are taking medicine for blood pressure and want to try for a baby (or have found they are pregnant) are given the best advice about the safety of different medicines for their baby
- women have good advice and support, including how to spot signs of pre-eclampsia (see the NHS website) and what to do
- care teams give women the right follow-up care and check-ups after they have given birth.
- how it might affect your birth plan if you develop high blood pressure during your pregnancy
- how best to control your blood pressure after your baby is born, and what happens if you have to take medicine while breastfeeding
- your likelihood of developing high blood pressure in the future (including in future pregnancies)
© NICE 
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
The information provided by NICE was accurate at the time this article was issued.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions (side effects) after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals or patients are asked to report any suspected adverse reactions via the Yellow Card Scheme at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.
Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. We cannot provide individual medical advice. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
Sharable Article Link : https://keepmeinformed.eu/Article?articleGuid=e889cc1a-cd10-40b5-a2c2-ee02d9542072